Total Payments
$3,864
2024 Payments
$392.20
Companies
21
Transactions
179
Medicare Patients
2,111
Medicare Billing
$179,654
Payment Breakdown by Category
Food & Beverage$3,860 (99.9%)
Education$4.64 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,860 | 178 | 99.9% |
| Education | $4.64 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,632 | 37 | $0 (2024) |
| Lilly USA, LLC | $551.17 | 33 | $0 (2024) |
| Merck Sharp & Dohme LLC | $329.02 | 26 | $0 (2024) |
| GlaxoSmithKline, LLC. | $213.91 | 11 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $212.42 | 15 | $0 (2021) |
| Bayer Healthcare Pharmaceuticals Inc. | $181.93 | 9 | $0 (2024) |
| AbbVie Inc. | $155.71 | 11 | $0 (2023) |
| Amgen Inc. | $106.55 | 7 | $0 (2024) |
| PFIZER INC. | $96.92 | 6 | $0 (2024) |
| Biohaven Pharmaceutical Holding Company Ltd. | $72.91 | 4 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $392.20 | 22 | Lilly USA, LLC ($174.62) |
| 2023 | $386.20 | 23 | Lilly USA, LLC ($176.67) |
| 2022 | $590.55 | 35 | Novo Nordisk Inc ($204.57) |
| 2021 | $320.70 | 20 | AbbVie Inc. ($71.16) |
| 2020 | $323.94 | 21 | Merck Sharp & Dohme Corporation ($77.23) |
| 2019 | $245.06 | 6 | Novo Nordisk Inc ($232.11) |
| 2018 | $591.55 | 10 | Novo Nordisk Inc ($551.97) |
| 2017 | $1,014 | 42 | Novo Nordisk Inc ($577.52) |
All Payment Transactions
179 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $21.90 | General |
| Category: Diabetes | ||||||
| 11/18/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $18.60 | General |
| Category: Diabetes | ||||||
| 10/29/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $21.27 | General |
| Category: Diabetes | ||||||
| 10/23/2024 | Merck Sharp & Dohme LLC | LAGEVRIO (Drug) | Food and Beverage | In-kind items and services | $17.53 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 09/17/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.02 | General |
| Category: Inflammation | ||||||
| 08/06/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.27 | General |
| Category: Inflammation | ||||||
| 07/17/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.48 | General |
| Category: Cardio-renal | ||||||
| 06/13/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $20.68 | General |
| Category: Diabetes | ||||||
| 06/04/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.23 | General |
| Category: Inflammation | ||||||
| 05/29/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $20.98 | General |
| Category: Diabetes | ||||||
| 05/23/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $15.97 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 05/09/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $14.57 | General |
| Category: Endocrinology | ||||||
| 05/08/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $15.68 | General |
| Category: Diabetes | ||||||
| 04/16/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.21 | General |
| Category: Inflammation | ||||||
| 04/09/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $19.88 | General |
| Category: Diabetes | ||||||
| 03/14/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $19.22 | General |
| Category: Respiratory | ||||||
| 03/12/2024 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO | Food and Beverage | In-kind items and services | $18.83 | General |
| Category: Diabetes | ||||||
| 02/15/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.90 | General |
| Category: Respiratory | ||||||
| 02/09/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $24.95 | General |
| Category: RESPIRATORY | ||||||
| 01/29/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $14.49 | General |
| Category: Diabetes | ||||||
| 01/23/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.25 | General |
| Category: Inflammation | ||||||
| 01/11/2024 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO | Food and Beverage | In-kind items and services | $23.29 | General |
| Category: Diabetes | ||||||
| 12/07/2023 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO | Food and Beverage | In-kind items and services | $16.37 | General |
| Category: Diabetes | ||||||
| 11/28/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.34 | General |
| Category: Inflammation | ||||||
| 11/20/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $22.85 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 618 | 789 | $218,846 | $66,403 |
| 2022 | 13 | 537 | 658 | $167,082 | $46,487 |
| 2021 | 11 | 485 | 569 | $132,412 | $40,099 |
| 2020 | 10 | 471 | 594 | $64,333 | $26,666 |
Total Patients
2,111
Total Services
2,610
Medicare Billing
$179,654
Procedure Codes
46
All Medicare Procedures & Services
46 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 120 | 190 | $81,700 | $19,169 | 23.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 136 | 220 | $63,800 | $16,620 | 26.1% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 44 | 44 | $15,400 | $12,346 | 80.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 37 | 43 | $24,940 | $6,745 | 27.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 22 | 22 | $10,340 | $3,354 | 32.4% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 37 | 37 | $4,255 | $2,805 | 65.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 51 | 51 | $4,080 | $1,835 | 45.0% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 44 | 44 | $2,376 | $1,583 | 66.6% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 11 | 14 | $3,060 | $907.84 | 29.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 64 | 67 | $8,040 | $828.36 | 10.3% |
| 81002 | Urinalysis, manual test | Office | 2023 | 34 | 37 | $555.00 | $126.17 | 22.7% |
| 82272 | Stool analysis for blood, by peroxidase activity | Office | 2023 | 18 | 20 | $300.00 | $83.00 | 27.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 103 | 150 | $64,500 | $16,445 | 25.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 117 | 168 | $48,720 | $12,746 | 26.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 24 | 34 | $19,720 | $4,370 | 22.2% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 46 | 46 | $4,140 | $3,232 | 78.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 16 | 16 | $7,520 | $2,502 | 33.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 67 | 67 | $5,360 | $2,367 | 44.2% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 16 | 17 | $4,845 | $1,985 | 41.0% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 14 | 14 | $1,232 | $949.72 | 77.1% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 14 | 15 | $3,000 | $881.78 | 29.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 50 | 52 | $6,240 | $604.15 | 9.7% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 14 | 20 | $920.00 | $192.27 | 20.9% |
| 81002 | Urinalysis, manual test | Office | 2022 | 42 | 45 | $675.00 | $154.35 | 22.9% |
| 82272 | Stool analysis for blood, by peroxidase activity | Office | 2022 | 14 | 14 | $210.00 | $58.46 | 27.8% |
About Dr. Deba Banerji, MD
Dr. Deba Banerji, MD is a Internal Medicine healthcare provider based in Staten Island, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/29/2006. The National Provider Identifier (NPI) number assigned to this provider is 1073574240.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Deba Banerji, MD has received a total of $3,864 in payments from pharmaceutical and medical device companies, with $392.20 received in 2024. These payments were reported across 179 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($3,860).
As a Medicare-enrolled provider, Banerji has provided services to 2,111 Medicare beneficiaries, totaling 2,610 services with total Medicare billing of $179,654. Data is available for 4 years (2020–2023), covering 46 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Staten Island, NY
- Active Since 03/29/2006
- Last Updated 11/12/2012
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1073574240
Products in Payments
- Ozempic (Drug) $660.78
- Tresiba (Drug) $462.31
- TRULICITY (Drug) $309.89
- Victoza (Drug) $242.29
- JANUVIA (Drug) $195.21
- MOUNJARO (Drug) $188.62
- Kerendia (Drug) $181.93
- Rybelsus (Drug) $154.74
- TRELEGY ELLIPTA (Drug) $152.09
- XARELTO (Drug) $128.69
- SYNTHROID (Drug) $100.10
- Xultophy 100/3.6 (Drug) $93.38
- Otezla (Drug) $91.32
- INVOKANA (Drug) $83.73
- NURTEC ODT (Drug) $72.91
- NEXLETOL (Drug) $71.88
- Livalo (Drug) $54.06
- PAXLOVID (Drug) $53.09
- LINZESS (Drug) $40.96
- SHINGRIX (Biological) $40.01
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Staten Island
Dr. Seth Brum, M.d, M.D
Internal Medicine — Payments: $409,260
Internal Medicine $409,260
Dr. Maryann Lee, M.d, M.D
Internal Medicine — Payments: $115,406
Internal Medicine $115,406
Dr. Alexander Beylinson, D.o, D.O
Internal Medicine — Payments: $61,903
Internal Medicine $61,903
Dr. Miguel Tirado, M.d, M.D
Internal Medicine — Payments: $35,111
Internal Medicine $35,111
Dr. Alan Dunton, M.d, M.D
Internal Medicine — Payments: $34,946
Internal Medicine $34,946
Dr. John Zafaranloo, M.d, M.D
Internal Medicine — Payments: $29,178
Internal Medicine $29,178